This medicinal product is for diagnostic use only. Polibar is a diagnostic reagent for radiological examination of the gastro-intestinal tract. Polibar is indicated in adults and children.
The FDA has accepted the new drug application (NDA) for SH 201, the first palatable oral liquid of the related chemotherapeutic agent, for the treatment of certain forms of leukemia and other cancers
Topical as a bath additive. For the prophylactic treatment of eczemas at risk from infection.
For the relief of dry tickly coughs.
Foundation Medicine, Inc. announced that the FDA approved FoundationOne Liquid CDx, the Company’s comprehensive pan-tumor liquid biopsy test.
The purpose of this study is to compare the effectiveness and safety of golcadomide in combination with rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone (R-CHOP) chemotherapy vs placebo in combination with R-CHOP chemotherapy in participants with previously untreated high-risk large B-cell lymphoma (LBCL).
For the treatment of pruritus, eczema, dermatitis, and scaling skin conditions where an antipruritic and/or hydrating effect is required. It may also be used for the continued treatment and follow-up treatment of these skin diseases.
For the short-term relief of occasional constipation.
The FDA has approved Gammagard Liquid 10% [Immune Globulin Infusion (Human)] as a treatment for Mmultifocal Motor Neuropathy (MMN). This is...